LNTH - Lantheus Holdings, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Lantheus Holdings, Inc.
Lantheus Holdings Inc develops diagnostic products for the healthcare sector. Its chief product is imaging agents used by physicians in diagnostic procedures such as cardiac ultrasounds and X-ray imaging.
IPO Date: June 25, 2015
Sector: Healthcare
Industry: Medical Diagnostics and Research
Market Cap: $6.54B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.92 | 2.46%
Avg Daily Range (30 D): $0.19 | 0.19%
Avg Daily Range (90 D): $0.97 | 0.93%
Institutional Daily Volume
Avg Daily Volume: .6M
Avg Daily Volume (30 D): .8M
Avg Daily Volume (90 D): .98M
Trade Size
Avg Trade Size (Sh.): 64
Avg Trade Size (Sh.) (30 D): 72
Avg Trade Size (Sh.) (90 D): 68
Institutional Trades
Total Institutional Trades: 8,509
Avg Institutional Trade: $3.09M
Avg Institutional Trade (30 D): $4.62M
Avg Institutional Trade (90 D): $4.4M
Avg Institutional Trade Volume: .05M
Avg Institutional Trades (Per Day): 4
Market Closing Trades
Avg Closing Trade: $6.57M
Avg Closing Trade (30 D): $12.82M
Avg Closing Trade (90 D): $16.92M
Avg Closing Volume: 110.1K
 
News
Sep 30, 2026 @ 10:42 PM
Halper Sadeh LLC is Investigating Whether ITGR, FH...
Source: Halper Sadeh Llc
Sep 14, 2026 @ 9:49 PM
Curiumâ„¢ announces FDA approval of BEXLUTRY l...
Source: Na
Sep 8, 2026 @ 12:30 AM
Radioligand Therapy Market to Grow from USD 2.98 B...
Source: Sns Insider
Aug 4, 2026 @ 6:11 PM
Halper Sadeh LLC is Investigating Whether MKTX, SM...
Source: Halper Sadeh Llc
Aug 3, 2026 @ 11:38 AM
Curium Announces Definitive Agreement to Merge wit...
Source: Na
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $4.22 $1.15 $1.83
Diluted EPS $4.13 $1.11 $1.8
Revenue $1.56B $388.18M $377.33M
Gross Profit $936.02M $241.86M $230.92M
Net Income / Loss $275.31M $75.03M $118.42M
Operating Income / Loss $302.34M $100.22M $81.33M
Cost of Revenue $620.3M $146.33M $146.41M
Net Cash Flow $-102.25M $94.72M $139.47M
PE Ratio